XENE - Xenon Pharmaceuticals Inc.

QQQ $ 614.67 $ -7.09 (-1.14 %)

DIA $ 470.69 $ -1.34 (-0.28 %)

SPY $ 672.93 $ -3.54 (-0.52 %)

TLT $ 89.70 $ 0.14 (0.15 %)

GLD $ 366.36 $ -0.84 (-0.23 %)

Previous Close

$ 38.66

Open

$ 38.52

Bid

$ 38.19 x 65

Ask

$ 38.32 x 274

Day's Range

$ 38.05 - $ 39.02

52 Week Range

$ 26.74 - $ 46.00

Volume

1,097,115

Average Volume

Market Cap

2.99B

Beta (5Y Monthly)

$ 0.77

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-03-2025	09-30-2025	10-Q
2	08-11-2025	06-30-2025	10-Q
3	05-12-2025	03-31-2025	10-Q
4	02-27-2025	12-31-2024	10-K
5	11-12-2024	09-30-2024	10-Q
6	08-08-2024	06-30-2024	10-Q
7	05-09-2024	03-31-2024	10-Q
8	02-29-2024	12-31-2023	10-K
9	11-08-2023	09-30-2023	10-Q
10	08-09-2023	06-30-2023	10-Q
11	05-09-2023	03-31-2023	10-Q
12	03-01-2023	12-31-2022	10-K
13	11-08-2022	09-30-2022	10-Q
14	08-09-2022	06-30-2022	10-Q
15	05-10-2022	03-31-2022	10-Q
16	03-01-2022	12-31-2021	10-K
17	11-10-2021	09-30-2021	10-Q
18	08-11-2021	06-30-2021	10-Q
19	05-11-2021	03-31-2021	10-Q
20	03-01-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	08-06-2020	06-30-2020	10-Q
23	05-21-2020	03-31-2020	10-Q
24	03-09-2020	12-31-2019	10-K
25	11-05-2019	09-30-2019	10-Q
26	08-06-2019	06-30-2019	10-Q
27	05-07-2019	03-31-2019	10-Q
28	03-06-2019	12-31-2018	10-K
29	11-06-2018	09-30-2018	10-Q
30	08-07-2018	06-30-2018	10-Q
31	05-08-2018	03-31-2018	10-Q
32	03-07-2018	12-31-2017	10-K
33	11-07-2017	09-30-2017	10-Q
34	08-03-2017	06-30-2017	10-Q
35	05-09-2017	03-31-2017	10-Q
36	03-08-2017	12-31-2016	10-K
37	11-03-2016	09-30-2016	10-Q
38	08-03-2016	06-30-2016	10-Q
39	05-10-2016	03-31-2016	10-Q
40	03-08-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

RBC Capital Maintains Outperform on Xenon ...
11/04/2025 16:47:30

RBC Capital analyst Brian Abrahams maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and raises the price targ...

Wells Fargo Maintains Overweight on Xenon ...
11/04/2025 16:04:47

Wells Fargo analyst Benjamin Burnett maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Overweight and lowers the price ta...

CORRECTION: Xenon Pharmaceuticals Ticker I...
11/04/2025 13:45:09

Needham Reiterates Buy on Xenon Pharmaceut...
11/04/2025 09:17:43

Needham analyst Serge Belanger reiterates Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and maintains $55 price target.

Xenon Pharmaceuticals Q3 EPS $(1.15), Inli...
11/03/2025 21:02:03

Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(1.15) per share which met the analyst consensus estimate. Th...

Earnings Scheduled For November 3, 2025
11/03/2025 11:11:31

Insights into Xenon Pharmaceuticals's Upco...
10/31/2025 17:01:11

Xenon Pharmaceutical Appoints Tucker Kelly...
10/16/2025 12:32:14

VANCOUVER, British Columbia and BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neurosci...

Chardan Capital Maintains Buy on Xenon Pha...
10/07/2025 11:45:44

Chardan Capital analyst Rudy Li maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and maintains $55 price target.

Wells Fargo Assumes Xenon Pharmaceuticals ...
09/03/2025 12:54:29

Wells Fargo analyst Benjamin Burnett assumes Xenon Pharmaceuticals (NASDAQ:XENE) with a Overweight rating and announces Pric...

RBC Capital Reiterates Outperform on Xenon...
09/02/2025 13:30:13

RBC Capital analyst Brian Abrahams reiterates Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and maintains $55 price ...

Chardan Capital Maintains Buy on Xenon Pha...
08/12/2025 20:30:47

Chardan Capital analyst Rudy Li maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and maintains $55 price target.

RBC Capital Maintains Outperform on Xenon ...
08/12/2025 14:14:34

RBC Capital analyst Brian Abrahams maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and lowers the price targ...

CORRECTION: Xenon Pharmaceuticals Q2 EPS $...
08/12/2025 13:51:46

Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(1.07) per share which missed the analyst consensus estimate ...

Wedbush Maintains Outperform on Xenon Phar...
08/12/2025 13:27:02

Wedbush analyst Laura Chico maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and raises the price target from...

Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

A Look Ahead: Xenon Pharmaceuticals's Earn...
08/08/2025 14:07:07

Xenon Pharma Added To Russell 3000 And Rus...
06/27/2025 20:02:21

Evercore ISI Group Initiates Coverage On X...
05/14/2025 15:51:27

Evercore ISI Group analyst Cory Kasimov initiates coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform rating a...

Wells Fargo Maintains Overweight on Xenon ...
05/13/2025 18:39:52

Wells Fargo analyst Mohit Bansal maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Overweight and lowers the price target...